2814 related articles for article (PubMed ID: 32246941)
1. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Oesophageal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
[TBL] [Abstract][Full Text] [Related]
2. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
GBD 2015 Chronic Respiratory Disease Collaborators
Lancet Respir Med; 2017 Sep; 5(9):691-706. PubMed ID: 28822787
[TBL] [Abstract][Full Text] [Related]
3. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Risk Factor Collaborators
Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
[TBL] [Abstract][Full Text] [Related]
4. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diseases and Injuries Collaborators
Lancet; 2024 May; 403(10440):2133-2161. PubMed ID: 38642570
[TBL] [Abstract][Full Text] [Related]
5. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Cirrhosis Collaborators
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
[TBL] [Abstract][Full Text] [Related]
6. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
GBD 2017 Stomach Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):42-54. PubMed ID: 31648970
[TBL] [Abstract][Full Text] [Related]
7. Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Respiratory Tract Cancers Collaborators
Lancet Respir Med; 2021 Sep; 9(9):1030-1049. PubMed ID: 34411511
[TBL] [Abstract][Full Text] [Related]
8. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
GBD 2021 Forecasting Collaborators
Lancet; 2024 May; 403(10440):2204-2256. PubMed ID: 38762325
[TBL] [Abstract][Full Text] [Related]
9. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Stroke Collaborators
Lancet Neurol; 2021 Oct; 20(10):795-820. PubMed ID: 34487721
[TBL] [Abstract][Full Text] [Related]
10. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Diseases and Injuries Collaborators
Lancet; 2020 Oct; 396(10258):1204-1222. PubMed ID: 33069326
[TBL] [Abstract][Full Text] [Related]
11. The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Gastro-oesophageal Reflux Disease Collaborators
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):561-581. PubMed ID: 32178772
[TBL] [Abstract][Full Text] [Related]
12. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Diabetes Collaborators
Lancet; 2023 Jul; 402(10397):203-234. PubMed ID: 37356446
[TBL] [Abstract][Full Text] [Related]
13. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
GBD 2015 Tobacco Collaborators
Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
[TBL] [Abstract][Full Text] [Related]
14. Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Brain and Other CNS Cancer Collaborators
Lancet Neurol; 2019 Apr; 18(4):376-393. PubMed ID: 30797715
[TBL] [Abstract][Full Text] [Related]
15. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Risk Factors Collaborators
Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
[TBL] [Abstract][Full Text] [Related]
16. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Colorectal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2019 Dec; 4(12):913-933. PubMed ID: 31648977
[TBL] [Abstract][Full Text] [Related]
17. Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Colorectal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):627-647. PubMed ID: 35397795
[TBL] [Abstract][Full Text] [Related]
18. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Adolescent Young Adult Cancer Collaborators
Lancet Oncol; 2022 Jan; 23(1):27-52. PubMed ID: 34871551
[TBL] [Abstract][Full Text] [Related]
19. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Inflammatory Bowel Disease Collaborators
Lancet Gastroenterol Hepatol; 2020 Jan; 5(1):17-30. PubMed ID: 31648971
[TBL] [Abstract][Full Text] [Related]
20. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019.
Safiri S; Kolahi AA; Naghavi M;
BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34844997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
